MRGPRX2 and Stroke: Thus, we show here that osthole acts via a Mrgprb2-dependent manner to inhibit post-stroke inflammation and improve outcomes, providing evidence that perhaps inhibition of MRGPRX2 may be a promising therapeutic in combating post-stroke neuroinflammation in human patients.